Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration

Detalhes bibliográficos
Autor(a) principal: Tasca, Karen Ingrid [UNESP]
Data de Publicação: 2018
Outros Autores: Correa, Camila Renata [UNESP], Caleffi, Juliana Trindade [UNESP], Mendes, Monica Banwart [UNESP], Gatto, Mariana [UNESP], Manfio, Vanessa Martinez [UNESP], Camargo, Caio Cavassan de [UNESP], Tavares, Francilene Capel [UNESP], Biasin, Mara, Souza, Lenice do Rosario de [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1155/2018/7531718
http://hdl.handle.net/11449/164123
Resumo: We aimed to analyze markers of immune activation, inflammation, and oxidative stress in 92 asymptomatic HIV-infected patients according to the adequate (AR, >500 cells/mm(3)) or inadequate (IR, <500 cells/mm(3)) CD4(+) T recovery and the presence or absence of antiretroviral treatment (cART). In relation to those newly diagnosed, they were divided into two groups, cART-naive IR (nIR) and cART-naive AR (nAR). Among those diagnosed more than five years ago, the following division was made: the cART-naive long-term nonprogressors (LTNP); patient under cART and AR (tAR); and patients under cART and IR (tIR). We investigated the expression of soluble receptor for advanced glycation end products (sRAGE), high-mobility group-box protein -1 (HMGB1), soluble CD14 (sCD14), IL-8, IL-10, 8-isoprostane, vitamins, and DNA damage. We observed higher levels of sRAGE in tAR as compared to nIR, nAR, LTNP, and more sCD14 than in nIR and nAR. As for IL-10 levels, we found nIR > nAR > LTNP > tAR > tIR. Higher levels of 8-isoprostane were observed in nIR. LTNP presented a higher retinol dosage than tAR and less genotoxic damage induced by oxidative stress than the other groups. We suggest that the therapy, despite being related to lesser immune activation and inflammation, alters the vitamin profile and consequently increases the oxidative stress of patients. In addition, the lowest genotoxic index for LTNP indicates that both VL and cART could be responsible for the increased DNA damage. More studies are needed to understand the influence of cART on persistent immune activation and inflammation.
id UNSP_e2f8594490afd3828c079a800fec4b5e
oai_identifier_str oai:repositorio.unesp.br:11449/164123
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell RestorationWe aimed to analyze markers of immune activation, inflammation, and oxidative stress in 92 asymptomatic HIV-infected patients according to the adequate (AR, >500 cells/mm(3)) or inadequate (IR, <500 cells/mm(3)) CD4(+) T recovery and the presence or absence of antiretroviral treatment (cART). In relation to those newly diagnosed, they were divided into two groups, cART-naive IR (nIR) and cART-naive AR (nAR). Among those diagnosed more than five years ago, the following division was made: the cART-naive long-term nonprogressors (LTNP); patient under cART and AR (tAR); and patients under cART and IR (tIR). We investigated the expression of soluble receptor for advanced glycation end products (sRAGE), high-mobility group-box protein -1 (HMGB1), soluble CD14 (sCD14), IL-8, IL-10, 8-isoprostane, vitamins, and DNA damage. We observed higher levels of sRAGE in tAR as compared to nIR, nAR, LTNP, and more sCD14 than in nIR and nAR. As for IL-10 levels, we found nIR > nAR > LTNP > tAR > tIR. Higher levels of 8-isoprostane were observed in nIR. LTNP presented a higher retinol dosage than tAR and less genotoxic damage induced by oxidative stress than the other groups. We suggest that the therapy, despite being related to lesser immune activation and inflammation, alters the vitamin profile and consequently increases the oxidative stress of patients. In addition, the lowest genotoxic index for LTNP indicates that both VL and cART could be responsible for the increased DNA damage. More studies are needed to understand the influence of cART on persistent immune activation and inflammation.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Reitoria/UNESPFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Univ Estadual Paulista, UNESP, Botucatu Med Sch FMB, Dept Trop Dis, Botucatu, SP, BrazilUNESP, FMB, Dept Pathol, Botucatu, SP, BrazilUniv Milan, Dept Biomed & Clin Sci, Milan, ItalyUniv Estadual Paulista, UNESP, Botucatu Med Sch FMB, Dept Trop Dis, Botucatu, SP, BrazilUNESP, FMB, Dept Pathol, Botucatu, SP, BrazilFAPESP: 2010/139225Hindawi LtdUniversidade Estadual Paulista (Unesp)Univ MilanTasca, Karen Ingrid [UNESP]Correa, Camila Renata [UNESP]Caleffi, Juliana Trindade [UNESP]Mendes, Monica Banwart [UNESP]Gatto, Mariana [UNESP]Manfio, Vanessa Martinez [UNESP]Camargo, Caio Cavassan de [UNESP]Tavares, Francilene Capel [UNESP]Biasin, MaraSouza, Lenice do Rosario de [UNESP]2018-11-26T17:49:12Z2018-11-26T17:49:12Z2018-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article11application/pdfhttp://dx.doi.org/10.1155/2018/7531718Journal Of Immunology Research. London: Hindawi Ltd, 11 p., 2018.2314-8861http://hdl.handle.net/11449/16412310.1155/2018/7531718WOS:000430602000001WOS000430602000001.pdf50205598265681820000-0003-1948-5071Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal Of Immunology Research1,352info:eu-repo/semantics/openAccess2024-09-03T13:14:42Zoai:repositorio.unesp.br:11449/164123Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T13:14:42Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
title Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
spellingShingle Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
Tasca, Karen Ingrid [UNESP]
title_short Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
title_full Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
title_fullStr Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
title_full_unstemmed Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
title_sort Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
author Tasca, Karen Ingrid [UNESP]
author_facet Tasca, Karen Ingrid [UNESP]
Correa, Camila Renata [UNESP]
Caleffi, Juliana Trindade [UNESP]
Mendes, Monica Banwart [UNESP]
Gatto, Mariana [UNESP]
Manfio, Vanessa Martinez [UNESP]
Camargo, Caio Cavassan de [UNESP]
Tavares, Francilene Capel [UNESP]
Biasin, Mara
Souza, Lenice do Rosario de [UNESP]
author_role author
author2 Correa, Camila Renata [UNESP]
Caleffi, Juliana Trindade [UNESP]
Mendes, Monica Banwart [UNESP]
Gatto, Mariana [UNESP]
Manfio, Vanessa Martinez [UNESP]
Camargo, Caio Cavassan de [UNESP]
Tavares, Francilene Capel [UNESP]
Biasin, Mara
Souza, Lenice do Rosario de [UNESP]
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Univ Milan
dc.contributor.author.fl_str_mv Tasca, Karen Ingrid [UNESP]
Correa, Camila Renata [UNESP]
Caleffi, Juliana Trindade [UNESP]
Mendes, Monica Banwart [UNESP]
Gatto, Mariana [UNESP]
Manfio, Vanessa Martinez [UNESP]
Camargo, Caio Cavassan de [UNESP]
Tavares, Francilene Capel [UNESP]
Biasin, Mara
Souza, Lenice do Rosario de [UNESP]
description We aimed to analyze markers of immune activation, inflammation, and oxidative stress in 92 asymptomatic HIV-infected patients according to the adequate (AR, >500 cells/mm(3)) or inadequate (IR, <500 cells/mm(3)) CD4(+) T recovery and the presence or absence of antiretroviral treatment (cART). In relation to those newly diagnosed, they were divided into two groups, cART-naive IR (nIR) and cART-naive AR (nAR). Among those diagnosed more than five years ago, the following division was made: the cART-naive long-term nonprogressors (LTNP); patient under cART and AR (tAR); and patients under cART and IR (tIR). We investigated the expression of soluble receptor for advanced glycation end products (sRAGE), high-mobility group-box protein -1 (HMGB1), soluble CD14 (sCD14), IL-8, IL-10, 8-isoprostane, vitamins, and DNA damage. We observed higher levels of sRAGE in tAR as compared to nIR, nAR, LTNP, and more sCD14 than in nIR and nAR. As for IL-10 levels, we found nIR > nAR > LTNP > tAR > tIR. Higher levels of 8-isoprostane were observed in nIR. LTNP presented a higher retinol dosage than tAR and less genotoxic damage induced by oxidative stress than the other groups. We suggest that the therapy, despite being related to lesser immune activation and inflammation, alters the vitamin profile and consequently increases the oxidative stress of patients. In addition, the lowest genotoxic index for LTNP indicates that both VL and cART could be responsible for the increased DNA damage. More studies are needed to understand the influence of cART on persistent immune activation and inflammation.
publishDate 2018
dc.date.none.fl_str_mv 2018-11-26T17:49:12Z
2018-11-26T17:49:12Z
2018-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1155/2018/7531718
Journal Of Immunology Research. London: Hindawi Ltd, 11 p., 2018.
2314-8861
http://hdl.handle.net/11449/164123
10.1155/2018/7531718
WOS:000430602000001
WOS000430602000001.pdf
5020559826568182
0000-0003-1948-5071
url http://dx.doi.org/10.1155/2018/7531718
http://hdl.handle.net/11449/164123
identifier_str_mv Journal Of Immunology Research. London: Hindawi Ltd, 11 p., 2018.
2314-8861
10.1155/2018/7531718
WOS:000430602000001
WOS000430602000001.pdf
5020559826568182
0000-0003-1948-5071
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Journal Of Immunology Research
1,352
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 11
application/pdf
dc.publisher.none.fl_str_mv Hindawi Ltd
publisher.none.fl_str_mv Hindawi Ltd
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1810021372848504832